Minimally invasive palliative interventions in advanced lung cancer

Christopher Mallow, Margaret Hayes, Roy Semaan, Thomas J Smith, Russell Hales, Roy G Brower, Lonny Yarmus

Research output: Contribution to journalReview article

Abstract

Introduction: Lung cancer is the leading cause of cancer-related deaths in the United States. Nearly 85% of all lung cancers are diagnosed at a late stage, with an associated five-year survival rate of 4%. Malignant central airway obstruction and malignant pleural effusions occur in upwards of 30% of these patients. Many of these patients are in need of palliative interventions for symptom control and to help improve their quality of life. Areas covered: This review covers the treatment modalities of malignant central airway obstruction and malignant pleural effusion. PubMed was used to search for the most up to date and clinically relevant articles that guide current treatment strategies. This review focuses on rigid bronchoscopy and the tools used for the relief of central airway obstruction, as well as intra-pleural catheter use and pleurodesis for the management of malignant pleural effusions. Expert commentary: There are multiple treatment modalities that may be used to help alleviate the symptoms of malignant central airway obstruction and pleural effusion. The modality used depends on the urgency of the situation, and specific patient’s goals. An open dialog to understand the patient’s end of life goals is an important factor when choosing the appropriate treatment strategy.

Original languageEnglish (US)
Pages (from-to)605-614
Number of pages10
JournalExpert Review of Respiratory Medicine
Volume12
Issue number7
DOIs
StatePublished - Jul 3 2018

Fingerprint

Airway Obstruction
Malignant Pleural Effusion
Lung Neoplasms
Pleurodesis
Bronchoscopy
Pleural Effusion
Therapeutics
PubMed
Catheters
Survival Rate
Quality of Life
Neoplasms

Keywords

  • interventional pulmonology
  • lung cancer
  • Malignant central airway obstruction
  • malignant pleural effusion
  • palliative care

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health

Cite this

Minimally invasive palliative interventions in advanced lung cancer. / Mallow, Christopher; Hayes, Margaret; Semaan, Roy; Smith, Thomas J; Hales, Russell; Brower, Roy G; Yarmus, Lonny.

In: Expert Review of Respiratory Medicine, Vol. 12, No. 7, 03.07.2018, p. 605-614.

Research output: Contribution to journalReview article

@article{3815df298c7d49d29cb7121dc6883173,
title = "Minimally invasive palliative interventions in advanced lung cancer",
abstract = "Introduction: Lung cancer is the leading cause of cancer-related deaths in the United States. Nearly 85{\%} of all lung cancers are diagnosed at a late stage, with an associated five-year survival rate of 4{\%}. Malignant central airway obstruction and malignant pleural effusions occur in upwards of 30{\%} of these patients. Many of these patients are in need of palliative interventions for symptom control and to help improve their quality of life. Areas covered: This review covers the treatment modalities of malignant central airway obstruction and malignant pleural effusion. PubMed was used to search for the most up to date and clinically relevant articles that guide current treatment strategies. This review focuses on rigid bronchoscopy and the tools used for the relief of central airway obstruction, as well as intra-pleural catheter use and pleurodesis for the management of malignant pleural effusions. Expert commentary: There are multiple treatment modalities that may be used to help alleviate the symptoms of malignant central airway obstruction and pleural effusion. The modality used depends on the urgency of the situation, and specific patient’s goals. An open dialog to understand the patient’s end of life goals is an important factor when choosing the appropriate treatment strategy.",
keywords = "interventional pulmonology, lung cancer, Malignant central airway obstruction, malignant pleural effusion, palliative care",
author = "Christopher Mallow and Margaret Hayes and Roy Semaan and Smith, {Thomas J} and Russell Hales and Brower, {Roy G} and Lonny Yarmus",
year = "2018",
month = "7",
day = "3",
doi = "10.1080/17476348.2018.1486709",
language = "English (US)",
volume = "12",
pages = "605--614",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
publisher = "Expert Reviews Ltd.",
number = "7",

}

TY - JOUR

T1 - Minimally invasive palliative interventions in advanced lung cancer

AU - Mallow, Christopher

AU - Hayes, Margaret

AU - Semaan, Roy

AU - Smith, Thomas J

AU - Hales, Russell

AU - Brower, Roy G

AU - Yarmus, Lonny

PY - 2018/7/3

Y1 - 2018/7/3

N2 - Introduction: Lung cancer is the leading cause of cancer-related deaths in the United States. Nearly 85% of all lung cancers are diagnosed at a late stage, with an associated five-year survival rate of 4%. Malignant central airway obstruction and malignant pleural effusions occur in upwards of 30% of these patients. Many of these patients are in need of palliative interventions for symptom control and to help improve their quality of life. Areas covered: This review covers the treatment modalities of malignant central airway obstruction and malignant pleural effusion. PubMed was used to search for the most up to date and clinically relevant articles that guide current treatment strategies. This review focuses on rigid bronchoscopy and the tools used for the relief of central airway obstruction, as well as intra-pleural catheter use and pleurodesis for the management of malignant pleural effusions. Expert commentary: There are multiple treatment modalities that may be used to help alleviate the symptoms of malignant central airway obstruction and pleural effusion. The modality used depends on the urgency of the situation, and specific patient’s goals. An open dialog to understand the patient’s end of life goals is an important factor when choosing the appropriate treatment strategy.

AB - Introduction: Lung cancer is the leading cause of cancer-related deaths in the United States. Nearly 85% of all lung cancers are diagnosed at a late stage, with an associated five-year survival rate of 4%. Malignant central airway obstruction and malignant pleural effusions occur in upwards of 30% of these patients. Many of these patients are in need of palliative interventions for symptom control and to help improve their quality of life. Areas covered: This review covers the treatment modalities of malignant central airway obstruction and malignant pleural effusion. PubMed was used to search for the most up to date and clinically relevant articles that guide current treatment strategies. This review focuses on rigid bronchoscopy and the tools used for the relief of central airway obstruction, as well as intra-pleural catheter use and pleurodesis for the management of malignant pleural effusions. Expert commentary: There are multiple treatment modalities that may be used to help alleviate the symptoms of malignant central airway obstruction and pleural effusion. The modality used depends on the urgency of the situation, and specific patient’s goals. An open dialog to understand the patient’s end of life goals is an important factor when choosing the appropriate treatment strategy.

KW - interventional pulmonology

KW - lung cancer

KW - Malignant central airway obstruction

KW - malignant pleural effusion

KW - palliative care

UR - http://www.scopus.com/inward/record.url?scp=85049034254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049034254&partnerID=8YFLogxK

U2 - 10.1080/17476348.2018.1486709

DO - 10.1080/17476348.2018.1486709

M3 - Review article

VL - 12

SP - 605

EP - 614

JO - Expert Review of Respiratory Medicine

JF - Expert Review of Respiratory Medicine

SN - 1747-6348

IS - 7

ER -